These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 16611118)

  • 41. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.
    Lee JM; Cho JB; Ahn HC; Jung W; Jeong YJ
    J Microbiol Biotechnol; 2017 Nov; 27(11):2070-2073. PubMed ID: 28910865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PBDE: structure-activity studies for the inhibition of hepatitis C virus NS3 helicase.
    Salam KA; Furuta A; Noda N; Tsuneda S; Sekiguchi Y; Yamashita A; Moriishi K; Nakakoshi M; Tani H; Roy SR; Tanaka J; Tsubuki M; Akimitsu N
    Molecules; 2014 Apr; 19(4):4006-20. PubMed ID: 24699145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase.
    Liuzzi M; Kibler P; Bousquet C; Harji F; Bolger G; Garneau M; Lapeyre N; McCollum RS; Faucher AM; Simoneau B; Cordingley MG
    Antiviral Res; 2004 Dec; 64(3):161-70. PubMed ID: 15550269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
    Katsumata K; Chono K; Kato K; Ohtsu Y; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1339-46. PubMed ID: 23274658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus.
    Tanner JA; Zheng BJ; Zhou J; Watt RM; Jiang JQ; Wong KL; Lin YP; Lu LY; He ML; Kung HF; Kesel AJ; Huang JD
    Chem Biol; 2005 Mar; 12(3):303-11. PubMed ID: 15797214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3.
    Marecki JC; Aarattuthodiyil S; Byrd AK; Penthala NR; Crooks PA; Raney KD
    Bioorg Med Chem Lett; 2019 Feb; 29(3):430-434. PubMed ID: 30578035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target.
    Biswas S; Kleymann G; Swift M; Tiley LS; Lyall J; Aguirre-Hernández J; Field HJ
    J Antimicrob Chemother; 2008 May; 61(5):1044-7. PubMed ID: 18299638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards the design of flavivirus helicase/NTPase inhibitors: crystallographic and mutagenesis studies of the dengue virus NS3 helicase catalytic domain.
    Xu T; Sampath A; Chao A; Wen D; Nanao M; Luo D; Chene P; Vasudevan SG; Lescar J
    Novartis Found Symp; 2006; 277():87-97; discussion 97-101, 251-3. PubMed ID: 17319156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.
    Biswas S; Jennens L; Field HJ
    Arch Virol; 2007; 152(8):1489-500. PubMed ID: 17404685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of SARS coronavirus helicase by bismuth complexes.
    Yang N; Tanner JA; Wang Z; Huang JD; Zheng BJ; Zhu N; Sun H
    Chem Commun (Camb); 2007 Nov; (42):4413-5. PubMed ID: 17957304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New anti-HSV therapeutics target the helicase-primase complex.
    Crumpacker CS; Schaffer PA
    Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
    [No Abstract]   [Full Text] [Related]  

  • 53. Allostery in the dengue virus NS3 helicase: Insights into the NTPase cycle from molecular simulations.
    Davidson RB; Hendrix J; Geiss BJ; McCullagh M
    PLoS Comput Biol; 2018 Apr; 14(4):e1006103. PubMed ID: 29659571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.
    Adedeji AO; Singh K; Kassim A; Coleman CM; Elliott R; Weiss SR; Frieman MB; Sarafianos SG
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4894-8. PubMed ID: 24841268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helicase-primase as a target of new therapies for herpes simplex virus infections.
    James SH; Larson KB; Acosta EP; Prichard MN
    Clin Pharmacol Ther; 2015 Jan; 97(1):66-78. PubMed ID: 25670384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uncoupling of Protease
    Zheng F; Lu G; Li L; Gong P; Pan Z
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motif V regulates energy transduction between the flavivirus NS3 ATPase and RNA-binding cleft.
    Du Pont KE; Davidson RB; McCullagh M; Geiss BJ
    J Biol Chem; 2020 Feb; 295(6):1551-1564. PubMed ID: 31914411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical characterization of the equine arteritis virus helicase suggests a close functional relationship between arterivirus and coronavirus helicases.
    Seybert A; van Dinten LC; Snijder EJ; Ziebuhr J
    J Virol; 2000 Oct; 74(20):9586-93. PubMed ID: 11000230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated strategies for identifying leads that target the NS3 helicase of the hepatitis C virus.
    LaPlante SR; Padyana AK; Abeywardane A; Bonneau P; Cartier M; Coulombe R; Jakalian A; Wildeson-Jones J; Li X; Liang S; McKercher G; White P; Zhang Q; Taylor SJ
    J Med Chem; 2014 Mar; 57(5):2074-90. PubMed ID: 24467709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.